A virus well known for the painful cold sores it causes is currently being tested as a treatment for patients’ malignant tumors. New findings by researchers at the University of Calgary in Alberta show how the virus, herpes simplex virus 1 (HSV-1), does selective damage to cancerous tissue. That revelation could point researchers toward ways of exploiting HSV-1 to better fight cancer.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.